Management options for patients with GERD and persistent symptoms on proton pump inhibitors

recommendations from an expert panel

Rena Yadlapati, Michael F. Vaezi, Marcelo F. Vela, Stuart J. Spechler, Nicholas J. Shaheen, Joel Richter, Brian E. Lacy, David Katzka, Philip O. Katz, Peter J. Kahrilas, C. Prakash Gyawali, Lauren Gerson, Ronnie Fass, Donald O. Castell, Jenna Craft, Luke Hillman, John E. Pandolfino

Research output: Contribution to journalArticle

7 Citations (Scopus)

Abstract

Background: The aim of this study was to assess expert gastroenterologists’ opinion on treatment for distinct gastroesophageal reflux disease (GERD) profiles characterized by proton pump inhibitor (PPI) unresponsive symptoms. Methods: Fourteen esophagologists applied the RAND/UCLA Appropriateness Method to hypothetical scenarios with previously demonstrated GERD (positive pH-metry or endoscopy) and persistent symptoms despite double-dose PPI therapy undergoing pH-impedance monitoring on therapy. A priori thresholds included: esophageal acid exposure (EAE) time >6.0%; symptom-reflux association: symptom index >50% and symptom association probability >95%; >80 reflux events; large hiatal hernia: >3 cm. Primary outcomes were appropriateness of four invasive procedures (laparoscopic fundoplication, magnetic sphincter augmentation, transoral incisionless fundoplication, radiofrequency energy delivery) and preference for pharmacologic/behavioral therapy. Results: Laparoscopic fundoplication was deemed appropriate for elevated EAE, and moderately appropriate for positive symptom-reflux association for regurgitation and a large hiatal hernia with normal EAE. Magnetic sphincter augmentation was deemed moderately appropriate for elevated EAE without a large hiatal hernia. Transoral incisionless fundoplication and radiofrequency energy delivery were not judged appropriate in any scenario. Preference for non-invasive options was as follows: H2RA for elevated EAE, transient lower esophageal sphincter relaxation inhibitors for elevated reflux episodes, and neuromodulation/behavioral therapy for positive symptom-reflux association. Conclusion: For treatment of PPI unresponsive symptoms in proven GERD, expert esophagologists recommend invasive therapy only in the presence of abnormal reflux burden, with or without hiatal hernia, or regurgitation with positive symptom-reflux association and a large hiatus hernia. Non-invasive pharmacologic or behavioral therapies are preferred for all other scenarios.

Original languageEnglish (US)
Pages (from-to)1-7
Number of pages7
JournalAmerican Journal of Gastroenterology
DOIs
StateAccepted/In press - Apr 24 2018

Fingerprint

Proton Pump Inhibitors
Gastroesophageal Reflux
Hiatal Hernia
Fundoplication
Acids
Therapeutics
Lower Esophageal Sphincter
Expert Testimony
Electric Impedance
Endoscopy

ASJC Scopus subject areas

  • Hepatology
  • Gastroenterology

Cite this

Management options for patients with GERD and persistent symptoms on proton pump inhibitors : recommendations from an expert panel. / Yadlapati, Rena; Vaezi, Michael F.; Vela, Marcelo F.; Spechler, Stuart J.; Shaheen, Nicholas J.; Richter, Joel; Lacy, Brian E.; Katzka, David; Katz, Philip O.; Kahrilas, Peter J.; Gyawali, C. Prakash; Gerson, Lauren; Fass, Ronnie; Castell, Donald O.; Craft, Jenna; Hillman, Luke; Pandolfino, John E.

In: American Journal of Gastroenterology, 24.04.2018, p. 1-7.

Research output: Contribution to journalArticle

Yadlapati, R, Vaezi, MF, Vela, MF, Spechler, SJ, Shaheen, NJ, Richter, J, Lacy, BE, Katzka, D, Katz, PO, Kahrilas, PJ, Gyawali, CP, Gerson, L, Fass, R, Castell, DO, Craft, J, Hillman, L & Pandolfino, JE 2018, 'Management options for patients with GERD and persistent symptoms on proton pump inhibitors: recommendations from an expert panel', American Journal of Gastroenterology, pp. 1-7. https://doi.org/10.1038/s41395-018-0045-4
Yadlapati, Rena ; Vaezi, Michael F. ; Vela, Marcelo F. ; Spechler, Stuart J. ; Shaheen, Nicholas J. ; Richter, Joel ; Lacy, Brian E. ; Katzka, David ; Katz, Philip O. ; Kahrilas, Peter J. ; Gyawali, C. Prakash ; Gerson, Lauren ; Fass, Ronnie ; Castell, Donald O. ; Craft, Jenna ; Hillman, Luke ; Pandolfino, John E. / Management options for patients with GERD and persistent symptoms on proton pump inhibitors : recommendations from an expert panel. In: American Journal of Gastroenterology. 2018 ; pp. 1-7.
@article{d75f8d0c77324bfabc754cd0dc083555,
title = "Management options for patients with GERD and persistent symptoms on proton pump inhibitors: recommendations from an expert panel",
abstract = "Background: The aim of this study was to assess expert gastroenterologists’ opinion on treatment for distinct gastroesophageal reflux disease (GERD) profiles characterized by proton pump inhibitor (PPI) unresponsive symptoms. Methods: Fourteen esophagologists applied the RAND/UCLA Appropriateness Method to hypothetical scenarios with previously demonstrated GERD (positive pH-metry or endoscopy) and persistent symptoms despite double-dose PPI therapy undergoing pH-impedance monitoring on therapy. A priori thresholds included: esophageal acid exposure (EAE) time >6.0{\%}; symptom-reflux association: symptom index >50{\%} and symptom association probability >95{\%}; >80 reflux events; large hiatal hernia: >3 cm. Primary outcomes were appropriateness of four invasive procedures (laparoscopic fundoplication, magnetic sphincter augmentation, transoral incisionless fundoplication, radiofrequency energy delivery) and preference for pharmacologic/behavioral therapy. Results: Laparoscopic fundoplication was deemed appropriate for elevated EAE, and moderately appropriate for positive symptom-reflux association for regurgitation and a large hiatal hernia with normal EAE. Magnetic sphincter augmentation was deemed moderately appropriate for elevated EAE without a large hiatal hernia. Transoral incisionless fundoplication and radiofrequency energy delivery were not judged appropriate in any scenario. Preference for non-invasive options was as follows: H2RA for elevated EAE, transient lower esophageal sphincter relaxation inhibitors for elevated reflux episodes, and neuromodulation/behavioral therapy for positive symptom-reflux association. Conclusion: For treatment of PPI unresponsive symptoms in proven GERD, expert esophagologists recommend invasive therapy only in the presence of abnormal reflux burden, with or without hiatal hernia, or regurgitation with positive symptom-reflux association and a large hiatus hernia. Non-invasive pharmacologic or behavioral therapies are preferred for all other scenarios.",
author = "Rena Yadlapati and Vaezi, {Michael F.} and Vela, {Marcelo F.} and Spechler, {Stuart J.} and Shaheen, {Nicholas J.} and Joel Richter and Lacy, {Brian E.} and David Katzka and Katz, {Philip O.} and Kahrilas, {Peter J.} and Gyawali, {C. Prakash} and Lauren Gerson and Ronnie Fass and Castell, {Donald O.} and Jenna Craft and Luke Hillman and Pandolfino, {John E.}",
year = "2018",
month = "4",
day = "24",
doi = "10.1038/s41395-018-0045-4",
language = "English (US)",
pages = "1--7",
journal = "American Journal of Gastroenterology",
issn = "0002-9270",
publisher = "Nature Publishing Group",

}

TY - JOUR

T1 - Management options for patients with GERD and persistent symptoms on proton pump inhibitors

T2 - recommendations from an expert panel

AU - Yadlapati, Rena

AU - Vaezi, Michael F.

AU - Vela, Marcelo F.

AU - Spechler, Stuart J.

AU - Shaheen, Nicholas J.

AU - Richter, Joel

AU - Lacy, Brian E.

AU - Katzka, David

AU - Katz, Philip O.

AU - Kahrilas, Peter J.

AU - Gyawali, C. Prakash

AU - Gerson, Lauren

AU - Fass, Ronnie

AU - Castell, Donald O.

AU - Craft, Jenna

AU - Hillman, Luke

AU - Pandolfino, John E.

PY - 2018/4/24

Y1 - 2018/4/24

N2 - Background: The aim of this study was to assess expert gastroenterologists’ opinion on treatment for distinct gastroesophageal reflux disease (GERD) profiles characterized by proton pump inhibitor (PPI) unresponsive symptoms. Methods: Fourteen esophagologists applied the RAND/UCLA Appropriateness Method to hypothetical scenarios with previously demonstrated GERD (positive pH-metry or endoscopy) and persistent symptoms despite double-dose PPI therapy undergoing pH-impedance monitoring on therapy. A priori thresholds included: esophageal acid exposure (EAE) time >6.0%; symptom-reflux association: symptom index >50% and symptom association probability >95%; >80 reflux events; large hiatal hernia: >3 cm. Primary outcomes were appropriateness of four invasive procedures (laparoscopic fundoplication, magnetic sphincter augmentation, transoral incisionless fundoplication, radiofrequency energy delivery) and preference for pharmacologic/behavioral therapy. Results: Laparoscopic fundoplication was deemed appropriate for elevated EAE, and moderately appropriate for positive symptom-reflux association for regurgitation and a large hiatal hernia with normal EAE. Magnetic sphincter augmentation was deemed moderately appropriate for elevated EAE without a large hiatal hernia. Transoral incisionless fundoplication and radiofrequency energy delivery were not judged appropriate in any scenario. Preference for non-invasive options was as follows: H2RA for elevated EAE, transient lower esophageal sphincter relaxation inhibitors for elevated reflux episodes, and neuromodulation/behavioral therapy for positive symptom-reflux association. Conclusion: For treatment of PPI unresponsive symptoms in proven GERD, expert esophagologists recommend invasive therapy only in the presence of abnormal reflux burden, with or without hiatal hernia, or regurgitation with positive symptom-reflux association and a large hiatus hernia. Non-invasive pharmacologic or behavioral therapies are preferred for all other scenarios.

AB - Background: The aim of this study was to assess expert gastroenterologists’ opinion on treatment for distinct gastroesophageal reflux disease (GERD) profiles characterized by proton pump inhibitor (PPI) unresponsive symptoms. Methods: Fourteen esophagologists applied the RAND/UCLA Appropriateness Method to hypothetical scenarios with previously demonstrated GERD (positive pH-metry or endoscopy) and persistent symptoms despite double-dose PPI therapy undergoing pH-impedance monitoring on therapy. A priori thresholds included: esophageal acid exposure (EAE) time >6.0%; symptom-reflux association: symptom index >50% and symptom association probability >95%; >80 reflux events; large hiatal hernia: >3 cm. Primary outcomes were appropriateness of four invasive procedures (laparoscopic fundoplication, magnetic sphincter augmentation, transoral incisionless fundoplication, radiofrequency energy delivery) and preference for pharmacologic/behavioral therapy. Results: Laparoscopic fundoplication was deemed appropriate for elevated EAE, and moderately appropriate for positive symptom-reflux association for regurgitation and a large hiatal hernia with normal EAE. Magnetic sphincter augmentation was deemed moderately appropriate for elevated EAE without a large hiatal hernia. Transoral incisionless fundoplication and radiofrequency energy delivery were not judged appropriate in any scenario. Preference for non-invasive options was as follows: H2RA for elevated EAE, transient lower esophageal sphincter relaxation inhibitors for elevated reflux episodes, and neuromodulation/behavioral therapy for positive symptom-reflux association. Conclusion: For treatment of PPI unresponsive symptoms in proven GERD, expert esophagologists recommend invasive therapy only in the presence of abnormal reflux burden, with or without hiatal hernia, or regurgitation with positive symptom-reflux association and a large hiatus hernia. Non-invasive pharmacologic or behavioral therapies are preferred for all other scenarios.

UR - http://www.scopus.com/inward/record.url?scp=85045834286&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85045834286&partnerID=8YFLogxK

U2 - 10.1038/s41395-018-0045-4

DO - 10.1038/s41395-018-0045-4

M3 - Article

SP - 1

EP - 7

JO - American Journal of Gastroenterology

JF - American Journal of Gastroenterology

SN - 0002-9270

ER -